WE’RE GOING GRAY IN MAY
FROM OUR FOUNDER, CANDY HAMMERAS…
May is Brain Tumor Awareness Month, also known as a time when we come together to support and amplify the voices of the brain tumor community. As someone who has assisted cancer patients throughout my career, the health issues I'm most known for are brain tumors, including malignant and benign tumors in adults and children. I often receive requests for assistance in this area because brain tumors are rare, complex, and frightening for patients and families.
At Cancer Teamwork Response, we get to know our patients and families personally, including celebrating their successful treatment but, sadly, sometimes mourning the loss of loved ones. We understand that word-of-mouth spreads quickly in the small community of brain tumor patients when they feel vulnerable and require immediate attention. So I founded CTR - to connect patients at lightning speed to the best experts in their geographic location.
We're going "Gray in May" to highlight and honor a few essential individuals in the brain tumor and CTR community. Join us as we honor those impacted by brain tumors during Brain Tumor Awareness Month. Please support our efforts by donating to help us continue to provide free 24/7 assistance to all cancer patients. We also ask that you PAY IT FORWARD by sharing these stories to raise awareness of those in need. If communities don’t know we exist, we cannot be of service during a critical time of need. Please share, like, and repost!
Sincerely,
Candy Hammeras, CTR Founder
Here are some statistics we’d like to share from
The American Cancer Society:
The American Cancer Society’s estimates for brain and spinal cord tumors in the United States for 2023 include adults and children.
About 24,810 malignant tumors of the brain or spinal cord (14,280 in males and 10,530 in females) will be diagnosed. These numbers would be much higher if benign (non-cancer) tumors were also included.
About 18,990 people (11,020 males and 7,970 females) will die from brain and spinal cord tumors.